MTOR and idiopathic pulmonary fibrosis: In this sense, on the basis that administration of p110γ inhibitors has been shown to significantly prevent bleomycin-induced pulmonary fibrosis in rats [101], several experimental studies have been evaluating the efficacy of mTOR/PI3K inhibitors for the treatment of IPF [102].